Polythiol-containing, recombinant mannosylated-albumin is a superior CD68+/CD206+ Kupffer cell-targeted nano-antioxidant for the treatment of two acute hepatitis models

Since reactive oxygen species (ROS) derived from Kupffer cells (KC), especially CD68+ KC, play a key role in the induction of hepatic oxidative stress and injuries, we newly developed a polythiolated- and mannosylated-human serum albumin (SH-Man-HSA), a novel nano-antioxidant for delivering thiol to...

Full description

Bibliographic Details
Main Authors: Maeda, H., Hirata, K., Watanabe, H., Ishima, Y., Chuang, Victor, Taguchi, H., Inatsu, A., Kinoshita, M., Tanaka, M., Sasaki, Y., Otagiri, M., Maruyama, T.
Format: Journal Article
Published: American Society for Pharmacology and Experimental Therapeutics 2015
Subjects:
Online Access:http://hdl.handle.net/20.500.11937/40655
_version_ 1848755929620676608
author Maeda, H.
Hirata, K.
Watanabe, H.
Ishima, Y.
Chuang, Victor
Taguchi, H.
Inatsu, A.
Kinoshita, M.
Tanaka, M.
Sasaki, Y.
Otagiri, M.
Maruyama, T.
author_facet Maeda, H.
Hirata, K.
Watanabe, H.
Ishima, Y.
Chuang, Victor
Taguchi, H.
Inatsu, A.
Kinoshita, M.
Tanaka, M.
Sasaki, Y.
Otagiri, M.
Maruyama, T.
author_sort Maeda, H.
building Curtin Institutional Repository
collection Online Access
description Since reactive oxygen species (ROS) derived from Kupffer cells (KC), especially CD68+ KC, play a key role in the induction of hepatic oxidative stress and injuries, we newly developed a polythiolated- and mannosylated-human serum albumin (SH-Man-HSA), a novel nano-antioxidant for delivering thiol to CD68+ KC. In vitro electron paramagnetic resonance (EPR) coupled with an in vivo pharmacokinetic and immunohistochemical study showed that SH-Man-HSA possessed powerful radical scavenging activity and was rapidly and selectively delivered thiols to the liver via mannose receptor (CD206) presented on the CD68+ cells surface. SH-Man-HSA significantly improved the survival rate of concanavalin-A (Con-A) treated mice. Moreover, SH-Man-HSA exhibited excellent hepato-protective action, not by influencing TNF or IFN-? production that closely associated with Con-A induced hepatitis, but by suppressing ROS production. Interestingly, such protective effect of SH-Man-HSA was superior to N-acetylcysteine (NAC). This could be due to the difference in the inhibition of hepatic oxidative stress between two antioxidant depending upon their potential of thiol delivery to liver. Similar results were also observed for acetaminophen (APAP)-induced hepatopathy models. Flow cytometric data further confirmed that an increase of F4/80+/ROS+ cells was dramatically decreased by SH-Man-HSA. The administration of SH-Man-HSA at 4 hours following a Con-A or APAP injection also exhibited profound hepato-protective action against two experimental hepatitis models, while this was not observed in the case of NAC. Therefore, SH-Man-HSA has a great potential for use as a rescue therapy for hepatopathy as a nano-antioxidant because of its efficient and rapid delivery of thiols to CD68+/CD206+ KC.
first_indexed 2025-11-14T09:04:07Z
format Journal Article
id curtin-20.500.11937-40655
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T09:04:07Z
publishDate 2015
publisher American Society for Pharmacology and Experimental Therapeutics
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-406552017-09-13T13:41:44Z Polythiol-containing, recombinant mannosylated-albumin is a superior CD68+/CD206+ Kupffer cell-targeted nano-antioxidant for the treatment of two acute hepatitis models Maeda, H. Hirata, K. Watanabe, H. Ishima, Y. Chuang, Victor Taguchi, H. Inatsu, A. Kinoshita, M. Tanaka, M. Sasaki, Y. Otagiri, M. Maruyama, T. Kupffer cells antioxidants drug delivery macrophages liver disease Since reactive oxygen species (ROS) derived from Kupffer cells (KC), especially CD68+ KC, play a key role in the induction of hepatic oxidative stress and injuries, we newly developed a polythiolated- and mannosylated-human serum albumin (SH-Man-HSA), a novel nano-antioxidant for delivering thiol to CD68+ KC. In vitro electron paramagnetic resonance (EPR) coupled with an in vivo pharmacokinetic and immunohistochemical study showed that SH-Man-HSA possessed powerful radical scavenging activity and was rapidly and selectively delivered thiols to the liver via mannose receptor (CD206) presented on the CD68+ cells surface. SH-Man-HSA significantly improved the survival rate of concanavalin-A (Con-A) treated mice. Moreover, SH-Man-HSA exhibited excellent hepato-protective action, not by influencing TNF or IFN-? production that closely associated with Con-A induced hepatitis, but by suppressing ROS production. Interestingly, such protective effect of SH-Man-HSA was superior to N-acetylcysteine (NAC). This could be due to the difference in the inhibition of hepatic oxidative stress between two antioxidant depending upon their potential of thiol delivery to liver. Similar results were also observed for acetaminophen (APAP)-induced hepatopathy models. Flow cytometric data further confirmed that an increase of F4/80+/ROS+ cells was dramatically decreased by SH-Man-HSA. The administration of SH-Man-HSA at 4 hours following a Con-A or APAP injection also exhibited profound hepato-protective action against two experimental hepatitis models, while this was not observed in the case of NAC. Therefore, SH-Man-HSA has a great potential for use as a rescue therapy for hepatopathy as a nano-antioxidant because of its efficient and rapid delivery of thiols to CD68+/CD206+ KC. 2015 Journal Article http://hdl.handle.net/20.500.11937/40655 10.1124/jpet.114.219493 American Society for Pharmacology and Experimental Therapeutics unknown
spellingShingle Kupffer cells
antioxidants
drug delivery
macrophages
liver disease
Maeda, H.
Hirata, K.
Watanabe, H.
Ishima, Y.
Chuang, Victor
Taguchi, H.
Inatsu, A.
Kinoshita, M.
Tanaka, M.
Sasaki, Y.
Otagiri, M.
Maruyama, T.
Polythiol-containing, recombinant mannosylated-albumin is a superior CD68+/CD206+ Kupffer cell-targeted nano-antioxidant for the treatment of two acute hepatitis models
title Polythiol-containing, recombinant mannosylated-albumin is a superior CD68+/CD206+ Kupffer cell-targeted nano-antioxidant for the treatment of two acute hepatitis models
title_full Polythiol-containing, recombinant mannosylated-albumin is a superior CD68+/CD206+ Kupffer cell-targeted nano-antioxidant for the treatment of two acute hepatitis models
title_fullStr Polythiol-containing, recombinant mannosylated-albumin is a superior CD68+/CD206+ Kupffer cell-targeted nano-antioxidant for the treatment of two acute hepatitis models
title_full_unstemmed Polythiol-containing, recombinant mannosylated-albumin is a superior CD68+/CD206+ Kupffer cell-targeted nano-antioxidant for the treatment of two acute hepatitis models
title_short Polythiol-containing, recombinant mannosylated-albumin is a superior CD68+/CD206+ Kupffer cell-targeted nano-antioxidant for the treatment of two acute hepatitis models
title_sort polythiol-containing, recombinant mannosylated-albumin is a superior cd68+/cd206+ kupffer cell-targeted nano-antioxidant for the treatment of two acute hepatitis models
topic Kupffer cells
antioxidants
drug delivery
macrophages
liver disease
url http://hdl.handle.net/20.500.11937/40655